Shared dysregulated pathways lead to Parkinson's disease and diabetes - PubMed (original) (raw)
Review
Shared dysregulated pathways lead to Parkinson's disease and diabetes
Jose A Santiago et al. Trends Mol Med. 2013 Mar.
Abstract
Recent evidence indicates that Parkinson's disease and diabetes, both age-related chronic diseases, share remarkably similar dysregulated pathways. Exposure to environmental factors and genetic susceptibility play a role in the etiology and progression of both diseases. In light of recent findings, an intriguing hypothesis has emerged that suggests that mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and alterations in metabolism may lead to insulin resistance and, ultimately, to diabetes and/or neurodegeneration. In this article, we summarize the studies that have addressed the relationship between Parkinson's disease and diabetes and propose that disruptions in these shared molecular networks lead to both chronic diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
- System-based approaches to decode the molecular links in Parkinson's disease and diabetes.
Santiago JA, Potashkin JA. Santiago JA, et al. Neurobiol Dis. 2014 Dec;72 Pt A:84-91. doi: 10.1016/j.nbd.2014.03.019. Epub 2014 Apr 6. Neurobiol Dis. 2014. PMID: 24718034 Review. - Heredity in Parkinson's disease: new findings.
Lev N, Melamed E. Lev N, et al. Isr Med Assoc J. 2001 Jun;3(6):435-8. Isr Med Assoc J. 2001. PMID: 11433638 Review. - Dementia is associated with insulin resistance in patients with Parkinson's disease.
Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, De Bartolo M, Mungari P, Fonte G, Consoli D, Consoli A, Fava A. Bosco D, et al. J Neurol Sci. 2012 Apr 15;315(1-2):39-43. doi: 10.1016/j.jns.2011.12.008. Epub 2012 Jan 21. J Neurol Sci. 2012. PMID: 22265943 - Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Aviles-Olmos I, Limousin P, Lees A, Foltynie T. Aviles-Olmos I, et al. Brain. 2013 Feb;136(Pt 2):374-84. doi: 10.1093/brain/aws009. Epub 2012 Feb 17. Brain. 2013. PMID: 22344583 Review. - Mitochondrial pathology in Parkinson's disease.
Schapira AH. Schapira AH. Mt Sinai J Med. 2011 Nov-Dec;78(6):872-81. doi: 10.1002/msj.20303. Mt Sinai J Med. 2011. PMID: 22069211 Review.
Cited by
- Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).
Khalil I, Sayad R, Kedwany AM, Sayed HH, Caprara ALF, Rissardo JP. Khalil I, et al. Med Int (Lond). 2024 Sep 19;4(6):70. doi: 10.3892/mi.2024.194. eCollection 2024 Nov-Dec. Med Int (Lond). 2024. PMID: 39355336 Free PMC article. Review. - Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
Barilar JO, Knezovic A, Perhoc AB, Homolak J, Riederer P, Salkovic-Petrisic M. Barilar JO, et al. J Neural Transm (Vienna). 2020 Feb;127(2):231-250. doi: 10.1007/s00702-020-02152-8. Epub 2020 Feb 6. J Neural Transm (Vienna). 2020. PMID: 32030485 Free PMC article. Review. - Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program.
Santiago JA, Bottero V, Potashkin JA. Santiago JA, et al. Front Aging Neurosci. 2018 May 29;10:157. doi: 10.3389/fnagi.2018.00157. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29896099 Free PMC article. - Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
Santiago JA, Potashkin JA. Santiago JA, et al. PLoS One. 2015 Nov 13;10(11):e0142582. doi: 10.1371/journal.pone.0142582. eCollection 2015. PLoS One. 2015. PMID: 26566043 Free PMC article. - Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.
Victorino DB, Nejm M, Guimarães-Marques M, Scorza FA, Scorza CA. Victorino DB, et al. Pharmaceut Med. 2021 Jan;35(1):11-19. doi: 10.1007/s40290-020-00374-5. Epub 2021 Jan 7. Pharmaceut Med. 2021. PMID: 33409802
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical